A study to find a suitable dose of BI 1821736 and test whether it helps people with advanced cancer

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502125-17-00

Acronym

1467-0001

Enrollment

Registered

2023-09-08

Start date

2023-10-16

Completion date

2025-04-10

Last updated

2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026